SG49202A1 - Use of remacemide for the treatment of Parkinson's disease - Google Patents

Use of remacemide for the treatment of Parkinson's disease

Info

Publication number: SG49202A1
Authority: SG; Singapore
Prior art keywords: remacemide; parkinson; disease; treatment; conjuction
Prior art date: 1992-05-02

Application number

SG1996007583A

Other languages

English (en)

Inventor

Eric William Harris

Peter Johnson

Barry Ernest Watkins

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-02

Filing date

1993-04-30

Publication date

1998-05-18

1993-04-30 Application filed by Astra Ab filed Critical Astra Ab

1998-05-18 Publication of SG49202A1 publication Critical patent/SG49202A1/en

Links

YSGASDXSLKIKOD-UHFFFAOYSA-N 2-amino-N-(1,2-diphenylpropan-2-yl)acetamide Chemical compound C=1C=CC=CC=1C(C)(NC(=O)CN)CC1=CC=CC=C1 YSGASDXSLKIKOD-UHFFFAOYSA-N 0.000 title abstract 3
208000018737 Parkinson disease Diseases 0.000 title abstract 2
229950000659 remacemide Drugs 0.000 title abstract 2
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG1996007583A 1992-05-02 1993-04-30 Use of remacemide for the treatment of Parkinson's disease SG49202A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929209599A GB9209599D0 (en)	1992-05-02	1992-05-02	Novel therapy for the treatment of parkinsons disease

Publications (1)

Publication Number	Publication Date
SG49202A1 true SG49202A1 (en)	1998-05-18

Family

ID=10714969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996007583A SG49202A1 (en)	1992-05-02	1993-04-30	Use of remacemide for the treatment of Parkinson's disease

Country Status (16)

Country	Link
EP (1)	EP0637956B1 (de)
JP (1)	JP3542801B2 (de)
KR (1)	KR950701216A (de)
AT (1)	ATE181669T1 (de)
CA (1)	CA2134783C (de)
DE (1)	DE69325512T2 (de)
DK (1)	DK0637956T3 (de)
ES (1)	ES2135476T3 (de)
GB (1)	GB9209599D0 (de)
GR (1)	GR3031320T3 (de)
HU (1)	HU211305A9 (de)
IL (1)	IL105569A (de)
NZ (2)	NZ252728A (de)
SG (1)	SG49202A1 (de)
WO (1)	WO1993021910A1 (de)
ZA (1)	ZA933086B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025369A (en) *	1996-05-03	2000-02-15	The Board Of Regents Of The University Nebraska	N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
RU2170576C1 (ru) *	1999-11-15	2001-07-20	Государственное учреждение науки Институт токсикологии	Гидрохлориды замещенных ацетиленовых аминоспиртов, обладающие антигалоперидоловой активностью
EP2316468A1 (de)	2002-02-22	2011-05-04	Shire LLC	Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
WO2008095221A1 (en)	2007-02-07	2008-08-14	Gosforth Centre (Holdings) Pty Ltd	Treatment of adhd
MX2011001384A (es)	2008-08-06	2011-09-27	Gosforth Ct Holdings Pty Ltd	Composiciones y metodos para tratar trastornos psiquiatricos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU639722B2 (en) *	1989-10-27	1993-08-05	Astra Aktiebolag	Use of arylalkylamides in the treatment of neurodegenerative diseases
DE3940410A1 (de) *	1989-12-04	1991-06-06	Schering Ag	Neue verwendung von nmda-rezeptor-antagonisten

1992
- 1992-05-02 GB GB929209599A patent/GB9209599D0/en active Pending
1993
- 1993-04-30 CA CA002134783A patent/CA2134783C/en not_active Expired - Fee Related
- 1993-04-30 SG SG1996007583A patent/SG49202A1/en unknown
- 1993-04-30 KR KR1019940703908A patent/KR950701216A/ko not_active Ceased
- 1993-04-30 AT AT93911903T patent/ATE181669T1/de not_active IP Right Cessation
- 1993-04-30 EP EP93911903A patent/EP0637956B1/de not_active Expired - Lifetime
- 1993-04-30 JP JP51908793A patent/JP3542801B2/ja not_active Expired - Fee Related
- 1993-04-30 DE DE69325512T patent/DE69325512T2/de not_active Expired - Fee Related
- 1993-04-30 NZ NZ252728A patent/NZ252728A/en not_active IP Right Cessation
- 1993-04-30 DK DK93911903T patent/DK0637956T3/da active
- 1993-04-30 ES ES93911903T patent/ES2135476T3/es not_active Expired - Lifetime
- 1993-04-30 NZ NZ299042A patent/NZ299042A/en not_active IP Right Cessation
- 1993-04-30 IL IL105569A patent/IL105569A/xx not_active IP Right Cessation
- 1993-04-30 WO PCT/GB1993/000908 patent/WO1993021910A1/en not_active Ceased
- 1993-04-30 ZA ZA933086A patent/ZA933086B/xx unknown
1995
- 1995-06-23 HU HU95P/P00425P patent/HU211305A9/hu unknown
1999
- 1999-09-23 GR GR990402420T patent/GR3031320T3/el unknown

Also Published As

Publication number	Publication date
JPH07506105A (ja)	1995-07-06
DE69325512D1 (de)	1999-08-05
CA2134783C (en)	2002-08-13
WO1993021910A1 (en)	1993-11-11
DE69325512T2 (de)	1999-12-16
KR950701216A (ko)	1995-03-23
IL105569A0 (en)	1993-08-18
NZ299042A (en)	2000-07-28
JP3542801B2 (ja)	2004-07-14
EP0637956B1 (de)	1999-06-30
ZA933086B (en)	1993-11-01
GR3031320T3 (en)	1999-12-31
EP0637956A1 (de)	1995-02-15
CA2134783A1 (en)	1993-11-11
DK0637956T3 (da)	1999-11-22
IL105569A (en)	1997-11-20
ATE181669T1 (de)	1999-07-15
HU211305A9 (en)	1995-11-28
NZ252728A (en)	1996-11-26
ES2135476T3 (es)	1999-11-01
GB9209599D0 (en)	1992-06-17

Publication	Publication Date	Title
AU684059B2 (en)	1997-12-04	Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
FI20000720A7 (fi)	2000-03-29	Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
GR3031320T3 (en)	1999-12-31	Use of remacemide for the treatment of parkinson's disease.
NO302170B1 (no)	1998-02-02	Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav
HUT71838A (en)	1996-02-28	Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
ATE233085T1 (de)	2003-03-15	Arzneimittel zur topischen anwendung
NZ268039A (en)	1999-06-29	Use of efaroxan in treating parkinson's disease
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
FR2818147B1 (fr)	2005-06-10	Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
CA2170289A1 (en)	1995-03-16	A method of treating liver disease and like indications with vasodilating agents
RU96118559A (ru)	1999-01-10	Лекарственное средство
ITBO930460A0 (it)	1993-11-12	Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
IT1275987B1 (it)	1997-10-24	Composizione farmaceutica attiva nella cura di affezioni dermatologiche
ITMI940030A0 (it)	1994-01-14	Compressa farmaceutica ad eleavata e rapida disponibilita' del principio attivo in essa veicolato